Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.22.2.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 66,794 $ 836,874
Prepaid expenses 470,608 774,677
Total current assets 537,402 1,611,551
Investments held in Trust Account 863,845,224 862,549,773
Total Assets 864,382,626 864,161,324
Current liabilities:    
Accounts payable 10,890 8,047
Accrued expenses 2,000 162,917
Franchise tax payable 20,000 200,045
Income tax payable 219,373
Total current liabilities 252,263 371,009
Derivative warrant liabilities 7,567,080 30,268,330
Deferred underwriting commissions 30,187,500 30,187,500
Promissory note – related party 1,391,290 1,392,950
Deferred legal costs 1,471,696 957,588
Total liabilities 40,869,829 63,177,377
Commitments and Contingencies
Class A common stock subject to possible redemption, $0.0001 par value; 86,250,000 shares issued and outstanding at $10.01 per share redemption value at June 30, 2022 and December 31, 2021 863,225,192 862,500,000
Stockholders’ Deficit:    
Preferred stock, $0.0001 par value; 3,000,000 shares authorized; none issued or outstanding at June 30, 2022 and December 31, 2021
Class A common stock, $0.0001 par value; 300,000,000 shares authorized ; no non-redeemable shares issued or outsanding at June 30, 2022 and December 31, 2021
Class B common stock, $0.0001 par value; 30,000,000 shares authorized; 21,562,500 shares issued and outstanding at June 30, 2022 and December 31, 2021 2,156 2,156
Additional paid-in capital
Accumulated deficit (39,714,551) (61,518,209)
Total stockholders’ deficit (39,712,395) (61,516,053)
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit $ 864,382,626 $ 864,161,324